Medicalook
Medicalook

Clonazepamum

http://www.medicalook.com
Clonazepamum

Clonazepamum review





Clonazepamum belongs to a group of medicament called benzodiazepine, which includes diazepam or Valium and flurazepam. Clonazepamum enhances the effects of the GABA neurotransmitter, inhibiting activity in the brain.

Adults and children with various types of seizures, such as akinetic, petit mal, and myoclonus seizure, may take Clonazepamum. It is also effective for relieving short-term mood condition symptoms. This medicament can be used to complement other medicaments for seizure disorders.

Dosage of Clonazepamum depends on the patient and the condition being treated. Adults suffering from seizures take 1.5 milligrams three times a day. The dosage can be increased up to 1 milligram daily until the seizures are controlled. For patients with panic disorders the initial dose is .25 milligrams twice a day. The dose can be increased up to 1 milligram a day after 3 days.

The most common side effect is sedation. Almost half the patients taking Clonazepamum have experienced sedation, while 1/3 experience dizziness, unsteadiness, and weakness. Other side effects include cephalalgia, difficulty in sleeping, loss of orientation and depression.

Clonazepamum can result in physical dependence, typical with all benzodiazepines. Patients who suddenly stop using the medicament may feel side effects such as insomnia and agitation. Patients taking Clonazepamum for a longer period than prescribed by a physician may experience muscle cramping, seizure, vomiting, tremors, and sweating.

Like most antiepileptic medicaments, Clonazepamum results in an increased risk of users having a suicidal behavior. Patients who use Clonazepamum should balance such risk with the clinical requirement for antiepileptic medicament.

Clonazepamum also heightens the effects of medicaments that slow down the brain processes including alcohol, narcotics, and barbiturates.

Pregnant women are discouraged from taking Clonazepamum since it has been linked to fetal damage especially in the first few months of the pregnancy. Most physicians discourage pregnant women from taking Clonazepamum throughout their pregnancy.

Before taking Clonazepamum, patients should inform their physicians if they have any allergy especially to benzodiazepines such as lorazepam and diazepam. Patients with liver disease, glaucoma, medicament dependency, kidney disease, breathing disorder, and mental disorder should divulge their conditions before agreeing to take this medicament.

Taking Clonazepamum may make a patient dizzy or drowsy, so one should be cautious when driving or operating machinery. The elderly are also more susceptible to the side effects of Clonazepamum including confusion and drowsiness.

Clonazepamum can have serious negative interactions with sodium oxybate. If a patient is presently taking this medicament, he or she must immediately inform their physician before beginning to take Clonazepamum. Patients should also tell their physicians all of the medicaments - whether prescription or non-prescription - that they are taking.

Anti-depressants including fluoxetine, nefazodone, fluvoxamine can also have interactions with Clonazepamum. Other medicaments that result in drowsiness such as antihistamines, anti-mood condition, and anti-seizure medicaments may interact negatively with Clonazepamum.

Clonazepamum has the following structural formula:

Chemical structure of clonazepamum


• Molecular formula of clonazepamum is C15H10ClN3O3
• Chemical IUPAC Name is 6-(2-chlorophenyl)-9-nitro-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-3-one
• Molecular weight is 315.711 g/mol
Clonazepamum available : 0.5mg tablets, 1mg tablets, 2mg tablets

Generic name: Clonazepam

Brand name(s): Antelepsin, Antilepsin, Chlonazepam, Cloazepam, Clonopin, Iktorivil, Klonopin, Landsen, Rivotril

  Your Clonazepamum review